Buy RT10 (10mg)
What is RT10?
RT10 is a novel investigational drug developed to treat obesity and metabolic disorders by targeting three hormone pathways: GLP-1, GIP, and glucagon receptors. This triple agonist helps regulate appetite, enhance insulin sensitivity, and boost energy expenditure, leading to substantial and sustained weight loss. Early clinical studies show superior results compared to current weight-loss therapies, with additional benefits for liver function, blood sugar control, and cardiovascular markers. Administered as a once-weekly injection, RT is being explored as a powerful tool for managing obesity, type 2 diabetes, and related conditions. It remains under clinical investigation and is not yet FDA-approved.
The Benefits of RT10
RT10 is a next-generation investigational drug designed to support significant weight loss and improve metabolic health. It’s a triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors—three key pathways that regulate appetite, energy use, and blood sugar levels. In clinical trials, RT10 has shown unprecedented results in helping adults with obesity or overweight conditions reduce body weight, potentially beyond what’s been seen with current GLP-1 drugs. By combining multiple metabolic signals into one therapy, it offers a powerful, multi-faceted approach to managing obesity, type 2 diabetes, and related conditions.
RT10 (10mg) For Sale
Dosage (Male)
1–12 mg once weekly (titrated)
Dosage (Female)
1–12 mg once weekly (titrated)
Frequency
Once per week
Dosage Type
Subcutaneous Injection
Active Half-Life
6–7 days
Post-Cycle PCT
N/A












Reviews
There are no reviews yet.